India markets closed
  • BSE SENSEX

    45,079.55
    +446.90 (+1.00%)
     
  • Nifty 50

    13,258.55
    +124.65 (+0.95%)
     
  • USD/INR

    73.7570
    -0.1030 (-0.14%)
     
  • Dow

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • BTC-INR

    1,403,995.88
    -1,740.38 (-0.12%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • Hang Seng

    26,835.92
    +107.42 (+0.40%)
     
  • Nikkei

    26,751.24
    -58.13 (-0.22%)
     
  • EUR/INR

    89.4373
    -0.3135 (-0.35%)
     
  • GBP/INR

    99.1093
    -0.2988 (-0.30%)
     
  • AED/INR

    20.0370
    -0.0280 (-0.14%)
     
  • INR/JPY

    1.4092
    +0.0060 (+0.43%)
     
  • SGD/INR

    55.2400
    -0.1450 (-0.26%)
     

KORU Medical Systems Schedules Release of Third Quarter 2020 Financial Results and Conference Call

·1-min read

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company") today announced that it will release its financial results for the third quarter ended September 30, 2020 after the close of the financial markets on Tuesday, November 3, 2020. Management will host a conference call on Wednesday, November 4, 2020 at 9:00 am ET to discuss the results and business activities.

Interested parties may participate in the call by dialing:

  • (877) 407-9753 (Domestic) or

  • (201) 493-6739 (International)

Webcast registration: Click Here

Following the live call, a replay will be available for six months on the Company's website, www.korumedical.com under "Investor Relations."

About KORU Medical

KORU Medical manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information about the Company, please visit www.korumedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201027005713/en/

Contacts

The Equity Group Inc.
Devin Sullivan
Senior Vice President
212-836-9608
dsullivan@equityny.com

Kalle Ahl, CFA
Vice President
212-836-9614
kahl@equityny.com